These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35886988)

  • 1. Phagocytosis of Erythrocytes from Gaucher Patients Induces Phenotypic Modifications in Macrophages, Driving Them toward Gaucher Cells.
    Dupuis L; Chauvet M; Bourdelier E; Dussiot M; Belmatoug N; Le Van Kim C; Chêne A; Franco M
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease.
    Franco M; Collec E; Connes P; van den Akker E; Billette de Villemeur T; Belmatoug N; von Lindern M; Ameziane N; Hermine O; Colin Y; Le Van Kim C; Mignot C
    Blood; 2013 Jan; 121(3):546-55. PubMed ID: 23212518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sphingolipids overload on red blood cell properties in Gaucher disease.
    Dupuis L; Chipeaux C; Bourdelier E; Martino S; Reihani N; Belmatoug N; Billette de Villemeur T; Hivert B; Moussa F; Le Van Kim C; de Person M; Franco M
    J Cell Mol Med; 2020 Sep; 24(17):9726-9736. PubMed ID: 32767726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell lymphoma and myeloma in murine Gaucher's disease.
    Pavlova EV; Wang SZ; Archer J; Dekker N; Aerts JM; Karlsson S; Cox TM
    J Pathol; 2013 Sep; 231(1):88-97. PubMed ID: 23775597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.
    Panicker LM; Miller D; Awad O; Bose V; Lun Y; Park TS; Zambidis ET; Sgambato JA; Feldman RA
    Stem Cells; 2014 Sep; 32(9):2338-49. PubMed ID: 24801745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytometric study of the red blood cells in Gaucher disease reveals their abnormal shape that may be involved in increased erythrophagocytosis.
    Bratosin D; Tissier JP; Lapillonne H; Hermine O; de Villemeur TB; Cotoraci C; Montreuil J; Mignot C
    Cytometry B Clin Cytom; 2011 Jan; 80(1):28-37. PubMed ID: 20568298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease.
    Lefebvre T; Reihani N; Daher R; de Villemeur TB; Belmatoug N; Rose C; Colin-Aronovicz Y; Puy H; Le Van Kim C; Franco M; Karim Z
    Haematologica; 2018 Apr; 103(4):587-596. PubMed ID: 29305416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2
    Wang W; Liu W; Fidler T; Wang Y; Tang Y; Woods B; Welch C; Cai B; Silvestre-Roig C; Ai D; Yang YG; Hidalgo A; Soehnlein O; Tabas I; Levine RL; Tall AR; Wang N
    Circ Res; 2018 Nov; 123(11):e35-e47. PubMed ID: 30571460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically aged red blood cells undergo erythrophagocytosis in vivo but not in vitro.
    Gottlieb Y; Topaz O; Cohen LA; Yakov LD; Haber T; Morgenstern A; Weiss A; Chait Berman K; Fibach E; Meyron-Holtz EG
    Haematologica; 2012 Jul; 97(7):994-1002. PubMed ID: 22331264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher disease with foamy transformed macrophages and erythrophagocytic activity.
    Machaczka M; Klimkowska M; Regenthal S; Hägglund H
    J Inherit Metab Dis; 2011 Feb; 34(1):233-5. PubMed ID: 21113739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gaucher's disease - an overview about a sphingolipidosis].
    Tamò R; Hochuli M; Beuschlein F; Nowak A
    Ther Umsch; 2018 Nov; 75(4):209-214. PubMed ID: 30468119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development.
    Wątek M; Piktel E; Wollny T; Durnaś B; Fiedoruk K; Lech-Marańda E; Bucki R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin.
    Knutson MD; Oukka M; Koss LM; Aydemir F; Wessling-Resnick M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1324-8. PubMed ID: 15665091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis.
    Sgambato JA; Park TS; Miller D; Panicker LM; Sidransky E; Lun Y; Awad O; Bentzen SM; Zambidis ET; Feldman RA
    Stem Cells Transl Med; 2015 Aug; 4(8):878-86. PubMed ID: 26062980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrophagocytosis in Gaucher cells.
    Bitton A; Etzell J; Grenert JP; Wang E
    Arch Pathol Lab Med; 2004 Oct; 128(10):1191-2. PubMed ID: 15387692
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimization of ultra-high pressure liquid chromatography - tandem mass spectrometry determination in plasma and red blood cells of four sphingolipids and their evaluation as biomarker candidates of Gaucher's disease.
    Chipeaux C; de Person M; Burguet N; Billette de Villemeur T; Rose C; Belmatoug N; Héron S; Le Van Kim C; Franco M; Moussa F
    J Chromatogr A; 2017 Nov; 1525():116-125. PubMed ID: 29061473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher's disease and cancer: a sphingolipid perspective.
    Barth BM; Shanmugavelandy SS; Tacelosky DM; Kester M; Morad SA; Cabot MC
    Crit Rev Oncog; 2013; 18(3):221-34. PubMed ID: 23510065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease.
    Reed MC; Schiffer C; Heales S; Mehta AB; Hughes DA
    Mol Genet Metab; 2018 Aug; 124(4):278-286. PubMed ID: 29934064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron homeostasis and infIammatory biomarker analysis in patients with type 1 Gaucher disease.
    Medrano-Engay B; Irun P; Gervas-Arruga J; Andrade-Campos M; Andreu V; Alfonso P; Pocovi M; Giraldo P
    Blood Cells Mol Dis; 2014 Dec; 53(4):171-5. PubMed ID: 25153906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: monocytes from Gaucher disease patients as a model.
    Balreira A; Lacerda L; Miranda CS; Arosa FA
    Br J Haematol; 2005 Jun; 129(5):667-76. PubMed ID: 15916690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.